Status:
COMPLETED
The Incidence of Subclinical High-altitude Pulmonary Oedema at High Altitude
Lead Sponsor:
Institute of Mountain Emergency Medicine
Conditions:
Acute Mountain Sickness
Subclinical High Altitude Pulmonary Edema
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this investigation is to determine the incidence of silent interstitial pulmonary edema by chest ultrasound at moderate altitude (3905m). Secondary endpoints are to detect a suspected assoc...
Detailed Description
The high-altitude pulmonary edema (HAPE) is the leading cause of death from high altitude sickness. At moderate altitude (2500-4500m) the incidence (0.2-6%) may be underestimated because only clinical...
Eligibility Criteria
Inclusion
- healthy of age \>18y
Exclusion
- cardiac failure
- chronic kidney disease
- chronic pulmonary disease
- acute lung/heart/kidney/brain conditions
- neoplastic disease
- lack of consent
Key Trial Info
Start Date :
July 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01794130
Start Date
July 1 2011
End Date
July 1 2011
Last Update
February 18 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Mountain Emergency Medicine, Eurac research
Bolzano, Provincia autonoma di Bolzano, Italy, 39100